We invest. We operate. Deep tech. Health & Environment.

Fontem co-invests in deep tech startups in health and environment, then actively supports their development between two rounds of financing — where value is created or destroyed.

No capital without operations.

What is it? Learn more
Our model Investor.
Operator.
Health — MedTech

Medtech, Healthtech, Biotech. We invest before revenue: a validated PoC and a structured regulatory path matter more than early sales.

Environment — Energy

Cleantech, deep green tech, energy transition. Projects rooted in impact reduction, with a demonstrated PoC and industrial or institutional partners in validation phase.

For founders

From conviction
to closing.

Invest first. Operate deep. Connect at the right moment.

01 2 – 4 weeks
Selection

We analyze the project, market and team in depth. Technical, commercial and regulatory due diligence. We only enter a deal if we believe in the potential and the execution capacity.

Validated PoC Regulatory roadmap Founding team
02 J+30
Investment closing

Term sheet, co-investment, next-round objectives defined together. We can lead the round, or join it. Fontem syndicates its LPs and family offices alongside the round — ticket €100K–€300K, with follow-on capacity.

Co-investment Next round objectives Follow-up framework
03 6 – 18 months
Operation

The core of our engagement. Weekly to daily piloting on the value-creating levers: product execution, commercial traction, key hires, regulatory milestones, investor narrative.

Weekly reviews Traction & milestones Investor narrative
04 When ready
Next round

When the file is ready — not before. Partner-level introductions, prepared over 6 to 12 months, calibrated for the right investor profiles. We don't just introduce: we lead the round, all the way to closing.

Partner introductions Targeted roadshow Closing

Our projects

9 portfolio companies
MedTech · Diagnostics 2025
Signatur Biosciences

Breast cancer recurrence risk detection via PCR. Decentralized precision diagnostics. Imperial College spin-out — YC '22.

Studio
Discover
MedTech · Robotics 2025
Xivix

Dental surgical robotics. Precision and repeatability for practitioners, directly in the operating room.

Pre-invest
Discover
HealthTech · AI 2025
Studia

AI dedicated to medical writing. Accelerates the production of clinical and regulatory dossiers.

Studio
Discover
MedTech · Care 2026
Kando

Voice assistant and nurse call for senior residences. Simplifies coordination between residents and care teams, by voice.

Invest & Operate
Discover
MedTech · Surgery 2026
Unveil Surgical

Real-time ENT surgical navigation. Reduces intraoperative risks through augmented imaging.

Studio
Discover
MedTech · Regulatory 2026
NotBody.AI

Certification platform for software medical devices (SaMD). Speeds up regulatory-compliant market entry.

Stealth mode
TechMed · Research 2026
TrialZen

Clinical trials supply chain. Optimizes sourcing and logistics of studies to accelerate execution.

Pre-invest
Discover
MedTech · Imaging 2026
Oncoradiomics

Oncological imaging for clinical trials.

Invest & Operate
Studio 2026
We also build

When we identify an opportunity without a suitable lead, Fontem initiates the project, recruits co-founders and pilots the launch.

In progress
The founders

Three paths,
one shared conviction

Stéphane Dehousse
Stéphane Dehousse
Co-Founder & Managing Partner

Serial entrepreneur and investor. Co-founder of two startup studios, 10+ fundraises supported. Backs portfolio companies on finance, business, marketing and operations.

Samuël Voccia
Samuël Voccia
Co-Founder — IP, Regulatory & Science

PhD in chemistry, co-founder of ANMI (exited to Telix Pharmaceuticals — approaching $1B in revenue). Regulatory, patents and scientific evaluation expert on every health deal.

Ludovic Wouters
Ludovic Wouters
Co-Founder — Commercial & GTM

Co-founder and director of ANMI (exited to Telix Pharmaceuticals — approaching $1B in revenue). Backs portfolio companies on commercial and go-to-market with a US focus, and on M&A strategy.

Territory & ambition

Anchored in Liège,
active in Europe

Liège is our starting point — a dense scientific and industrial ecosystem, anchored by the University of Liège, the CHU hospital, and a tradition of DeepTech innovation. But our deals, partners and investors do not stop at the borders.

MedTech & Diagnostics Health
HealthTech & Medical AI Health
Biotech & Pharma Health
Cleantech & Energy Environment
Deep Green Tech Environment

Let's talk about your project

Before you write, take a moment to prepare :

No need for a deck at this stage. A clear message beats a polished pitch.
Response within 5 business days.

Fontem SRL ❤️ Liège - Belgium